Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder (Q35249650)

7 August 2017

Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder (English)

1 reference

7 August 2017

1 reference

Catherine A Martin

1

1 reference

7 August 2017

Greg Guenthner

2

1 reference

7 August 2017

Christopher Bingcang

3

1 reference

7 August 2017

Mary Kay Rayens

4

1 reference

7 August 2017

Thomas H Kelly

5

1 reference

7 August 2017

1 February 2007

1 reference

Journal of Child and Adolescent Psychopharmacology

7 August 2017

1 reference

7 August 2017

17

1 reference

7 August 2017

1

1 reference

7 August 2017

63-73

1 reference

Medical use, illicit use and diversion of prescription stimulant medication

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Assessing methylphenidate preference in ADHD patients using a choice procedure

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Methylphenidate for adolescents with minimal brain dysfunction.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Rating scales and checklists for child psychopharmacology.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Effects of methylphenidate hydrochloride on the subjective reporting of mood in children with attention deficit disorder.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Assessment of abuse liability of stimulant drugs in humans: a methodological survey

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

The use, misuse and diversion of prescription stimulants among middle and high school students.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184246

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

26 September 2018

1 reference

12 December 2020

Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment

1 reference

12 December 2020

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

12 December 2020

Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study

1 reference

12 December 2020

Attention Deficit Hyperactivity Disorder (ADHD) is Associated with Early Onset Substance Use Disorders

1 reference

12 December 2020

Identifiers

DOI

10.1089/CAP.2006.0020

1 reference

7 August 2017

1 reference

7 August 2017

1 reference